DYN
Price
$14.70
Change
+$0.71 (+5.08%)
Updated
Jun 6 closing price
Capitalization
1.67B
54 days until earnings call
PLUR
Price
$4.75
Change
-$0.03 (-0.63%)
Updated
Jun 6 closing price
Capitalization
37.62M
Interact to see
Advertisement

DYN vs PLUR

Header iconDYN vs PLUR Comparison
Open Charts DYN vs PLURBanner chart's image
Dyne Therapeutics
Price$14.70
Change+$0.71 (+5.08%)
Volume$2.67M
Capitalization1.67B
Pluri
Price$4.75
Change-$0.03 (-0.63%)
Volume$7.68K
Capitalization37.62M
DYN vs PLUR Comparison Chart
Loading...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DYN vs. PLUR commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYN is a StrongBuy and PLUR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (DYN: $14.70 vs. PLUR: $4.75)
Brand notoriety: DYN and PLUR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DYN: 104% vs. PLUR: 35%
Market capitalization -- DYN: $1.67B vs. PLUR: $37.62M
DYN [@Biotechnology] is valued at $1.67B. PLUR’s [@Biotechnology] market capitalization is $37.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYN’s FA Score shows that 1 FA rating(s) are green whilePLUR’s FA Score has 0 green FA rating(s).

  • DYN’s FA Score: 1 green, 4 red.
  • PLUR’s FA Score: 0 green, 5 red.
According to our system of comparison, DYN is a better buy in the long-term than PLUR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYN’s TA Score shows that 6 TA indicator(s) are bullish.

  • DYN’s TA Score: 6 bullish, 4 bearish.

Price Growth

DYN (@Biotechnology) experienced а +22.91% price change this week, while PLUR (@Biotechnology) price change was +6.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

DYN is expected to report earnings on Jul 31, 2025.

PLUR is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DYN($1.67B) has a higher market cap than PLUR($37.6M). PLUR YTD gains are higher at: 11.111 vs. DYN (-37.606). PLUR has higher annual earnings (EBITDA): -19.28M vs. DYN (-395.31M). DYN has more cash in the bank: 677M vs. PLUR (21.3M). DYN has less debt than PLUR: DYN (23.3M) vs PLUR (29.3M). PLUR has higher revenues than DYN: PLUR (678K) vs DYN (0).
DYNPLURDYN / PLUR
Capitalization1.67B37.6M4,444%
EBITDA-395.31M-19.28M2,050%
Gain YTD-37.60611.111-338%
P/E RatioN/AN/A-
Revenue0678K-
Total Cash677M21.3M3,178%
Total Debt23.3M29.3M80%
FUNDAMENTALS RATINGS
PLUR: Fundamental Ratings
PLUR
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DYN
RSI
ODDS (%)
Bearish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 1 day ago
85%
Declines
ODDS (%)
Bearish Trend 24 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XLO0.700.02
+3.20%
Xilio Therapeutics
AESI13.120.37
+2.90%
Atlas Energy Solutions
AEP101.790.02
+0.02%
American Electric Power Company
MEC15.00-0.02
-0.13%
Mayville Engineering Company
LU2.90-0.02
-0.68%
Lufax Holding Ltd

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with CRNX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
+5.08%
CRNX - DYN
57%
Loosely correlated
+2.13%
RNA - DYN
52%
Loosely correlated
+1.83%
XNCR - DYN
51%
Loosely correlated
+5.81%
RVMD - DYN
50%
Loosely correlated
+2.21%
IGMS - DYN
50%
Loosely correlated
+6.45%
More